Hemoperfusion plus continuous veno-venous hemofiltration in the treatment of patients with multiple organ failure after wasp stings

Abstract

Purpose:

This study aimed to evaluate the clinical effects of hemoperfusion plus continuous veno-venous hemofiltration in the treatment of patients with multiple organ failure after wasp stings and investigate its impacts on cytokines.

Methods:

A total of 12 patients with multiple organ failure after wasp stings admitted to Xijing Hospital were included in the present study between January 2017 and January 2019. All patients received hemoperfusion plus continuous veno-venous hemofiltration treatment in addition to conventional treatment after admission. Procedure of treatment was conducted as the following: hemoperfusion (2 h/day) and followed by continuous veno-venous hemofiltration (22 h/day) for at least 5 days. Patients’ clinical features, serum laboratory tests, and hemodynamic variables were monitored. The blood samples were taken to measure the changes of plasma cytokines.

Results:

All 12 patients survived in the observation period. After hemoperfusion plus continuous veno-venous hemofiltration treatment, there were significant improvements in indicators of liver function, renal function, state of consciousness, and mediators in blood circulation, including alanine transaminase, aspartate transaminase, creatine kinase, blood urea nitrogen, serum creatinine, myoglobin, C-reactive protein, and so on. In these patients, acid–base metabolism returned to normal levels; Acute Physiology and Chronic Health Evaluation II score, Simplified Acute Physiology Score II score, and Sequential Organ Failure Assessment score lowered markedly. Furthermore, the plasma levels of interleukin 1β, interleukin 4, interleukin 6, interleukin 8, and interleukin 10 in these patients were significantly decreased; no significant change was shown in the level of tumor necrosis factor α.

Conclusion:

Our results revealed that hemoperfusion plus continuous veno-venous hemofiltration was effective in the management of patients with multiple organ failure after wasp sting via the non-specific removal of the wasp venom and inflammatory cytokines.

Keywords

Hemoperfusion continuous veno-venous hemofiltration multiple organ failure wasp sting cytokine

Get full access to this article

View all access options for this article.

References

Franca

FOS

Benvenuti

Fan

, et al. Severe and fatal mass attacks by “killer” bees (Africanized honey bees—Apis mellifera scutellata) in Brazil: clinicopathological studies with measurement of serum venom concentrations. Q J Med 1994; 87(5): 269–282.

Sharmila

Chetan

Narayanan

, et al. Multiple organ dysfunction syndrome following single wasp sting. Indian J Pediatr 2007; 74(12): 1111–1112.

Xuan

Mai

Thi

, et al. Swarming hornet attacks: shock and acute kidney injury—a large case series from Vietnam. Nephrol Dial Transplant 2010; 25(4): 1146–1150.

Gong

Yuan

Gao

, et al. Wasp venom and acute kidney injury: the mechanisms and therapeutic role of renal replacement therapy. Toxicon 2019; 163: 1–7.

Bhatta

Singh

Sharma

, et al. Acute renal failure following multiple wasp stings. Pediatr Nephrol 2005; 20(12): 1809–1810.

Sachdev

Mahapatra

D’Cruz

, et al. Wasp sting induced neurological manifestations. Neurol India 2002; 50(3): 319–321.

Xie

Ding

, et al. Clinical features of severe wasp sting patients with dominantly toxic reaction: analysis of 1091 cases. PLoS ONE 2013; 8(12): e83164.

Petricevich

VL.

Cytokine and nitric oxide production following severe envenomation. Curr Drug Targets Inflamm Allergy 2004; 3(3): 325–332.

Vetter

Visscher

Camazine

Mass envenomations by honey bees and wasps. West J Med 1999; 170(4): 223–227.

10.

Peng

Pai

Hong-Bao

, et al. The impacts of continuous venovenous hemofiltration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients. Cytokine 2010; 50(2): 186–191.a

11.

Peng

Pai

Han-Min

, et al. Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: a preliminary study. Int J Artif Organs 2010; 33(8): 505–511.

12.

Akdis

Blesken

, et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98(7): 1676–1683.

13.

Barraviera

Lomonte

Tarkowski

, et al. Acute- phase reactions, including cytokines, in patients bitten by Bothrops and Crotalus snakes in Brazil. J Venom Anim Toxins 1995; 1(1): 11–22.

14.

Sofer

Gueron

White

, et al. Interleukin-6 release following scorpion sting in children. Toxicon 1996; 34(3): 389–392.

15.

Balkwill

Burke

The cytokine network. Immunol Today 1989; 10(9): 299–304.

16.

Dinarello

CA.

Biologic basis for interleukin-1 in disease. Blood 1996; 87(6): 2095–2147.

17.

Moldawer

LL.

Biology of proinflammatory cytokines and their antagonists. Crit Care Med 1994; 22(7): S3–S7.

18.

Bazzoni

Beutler

The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334(26): 1717–1725.

19.

Lee

Faubel

Edelstein

CL.

Cytokines in acute kidney injury (AKI). Clin Nephrol 2011; 76(3): 165–173.

20.

Opal

DePalo

VA.

Anti-inflammatory cytokines. Chest 2000; 117(4): 1162–1172.

21.

Chen

Jiang

Shan

, et al. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney. Int J Artif Organs 2011; 34(4): 339–347.

22.

Atan

Peck

Visvanathan

, et al. High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines. Int J Artif Organs 2016; 39(9): 479–486.

23.

Hoffmann

Hartl

Deppisch

, et al. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48(5): 1563–1570.

24.

Saito

Current progress in blood purification methods used in critical care medicine. Contrib Nephrol 2010; 166: 100–111.

25.

Ronco

Klein

DJ.

Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care 2014; 18(3): 309.

26.

Zagli

Bonizzoli

Spina

, et al. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 2010; 76(6): 405–412.

27.

Huang

Wang

, et al. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial 2010; 14(6): 596–602.

28.

Yin

Chen

, et al. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus. Medicine 2017; 96(12): e6160.

29.

Ruffell

AJ.

The utilization of continuous veno-venous hemofiltration for the removal of septic mediators in patients with systemic inflammatory response syndrome. Intensive Crit Care Nurs 2003; 19(4): 207–214.

30.

Heering

Grabensee

Brause

Cytokine removal in septic patients with continuous venovenous hemofiltration. Kidney Blood Press Res 2003; 26(2): 128–134.

31.

Ronco

Bellomo

Ricci

Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16(Suppl. 5): 67–72.

32.

Cole

Bellomo

Davenport

, et al. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Organs 2004; 27(5): 388–397.

33.

Kellum

Johnson

Kramer

Diffusive

vs.

, et al. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26(12): 1995–2000.

34.

Sander

Armbruster

Sander

, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations. Intensive Care Med 1997; 23(8): 878–884.